Interactions of short-acting, intermediate-acting and pre-mixed human insulins with free radicals--Comparative EPR examination. 2015

Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
Department of Community Pharmacy, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Kasztanowa 3, 41-200 Sosnowiec, Poland. Electronic address: polczyk@sum.edu.pl.

Electron paramagnetic resonance (EPR) spectroscopy was used to examine insulins interactions with free radicals. Human recombinant DNA insulins of three groups were studied: short-acting insulin (Insuman Rapid); intermediate-acting insulins (Humulin N, Insuman Basal), and pre-mixed insulins (Humulin M3, Gensulin M50, Gensulin M40, Gensulin M30). The aim of an X-band (9.3GHz) study was comparative analysis of antioxidative properties of the three groups of human insulins. DPPH was used as a stable free radical model. Amplitudes of EPR lines of DPPH as the paramagnetic free radical reference, and DPPH interacting with the individual tested insulins were compared. For all the examined insulins kinetics of their interactions with free radicals up to 60 min were obtained. The strongest interactions with free radicals were observed for the short-acting insulin - Insuman Rapid. The lowest interactions with free radicals were characteristic for intermediate-acting insulin - Insuman Basal. The pre-mixed insulins i.e. Humulin M3 and Gensulin M50 revealed the fastest interactions with free radicals. The short acting, intermediate acting and premixed insulins have been found to be effective agents in reducing free radical formation in vitro and should be further considered as potential useful tools in attenuation of oxidative stress in diabetic patients.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004578 Electron Spin Resonance Spectroscopy A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING. ENDOR,Electron Nuclear Double Resonance,Electron Paramagnetic Resonance,Paramagnetic Resonance,Electron Spin Resonance,Paramagnetic Resonance, Electron,Resonance, Electron Paramagnetic,Resonance, Electron Spin,Resonance, Paramagnetic
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068880 Isophane Insulin, Human Human isophane insulin that is used to manage BLOOD GLUCOSE levels in patients with DIABETES. Humulin N,Insulatard,Insulin, NPH, Human,NPH Insulin, Human,Novolin N,Protophan,Protophane,Human Isophane Insulin,Human NPH Insulin,Insulin, Human Isophane,Insulin, Human NPH,N, Humulin,N, Novolin
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D061386 Insulin, Regular, Human Regular insulin preparations that contain the HUMAN insulin peptide sequence. Humulin,Humulin S
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative

Related Publications

Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
January 1985, The Netherlands journal of medicine,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
March 1983, Archives of internal medicine,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
December 1983, Diabetes,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
January 1993, Diabetes research (Edinburgh, Scotland),
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
May 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
September 1986, The American journal of medicine,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
January 1987, Diabetes research (Edinburgh, Scotland),
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
January 1986, Diabetes care,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
December 1984, Diabetologia,
Paweł Olczyk, and Katarzyna Komosinska-Vassev, and Paweł Ramos, and Łukasz Mencner, and Krystyna Olczyk, and Barbara Pilawa
March 1985, British medical journal (Clinical research ed.),
Copied contents to your clipboard!